抗抑郁药与心血管药物在活性炭上的吸附:阿米替林、安非他酮、米诺地尔、普萘洛尔和文拉法辛
该研究通过模拟胃液(pH 1.2)和模拟肠液(pH 6.8)中的动力学与吸附等温线实验,评估阿米替林、安非他酮、米诺地尔、普萘洛尔和文拉法辛在活性炭上的吸附。结果显示五种药物均被有效吸附,但吸附效率随pH变化;所有药物在模拟肠液中的最大吸附容量高于模拟胃液,但结合强度在模拟胃液中更强。在模拟肠液中,安非他酮在活性炭药物比10:1时达到≥95%吸附,而模拟胃液中即使12:1也未达到;阿米替林和普萘洛尔在低于10:1的比例下即达≥95%吸附;文拉法辛和米诺地尔需要更高比例。作者认为,单次50 g活性炭在10:1比例下可能不足以应对安非他酮、米诺地尔和文拉法辛的临床显著过量,尤其是速释安非他酮。
要点
- 在模拟肠液中,安非他酮在活性炭药物比10:1时≥95%被吸附;模拟胃液中即使12:1也未达到该水平。
- 阿米替林和普萘洛尔在活性炭药物比低于10:1时即达到≥95%吸附。
- 文拉法辛和米诺地尔需要更高的活性炭药物比才能达到最大吸附。
- 所有药物在模拟肠液中的最大吸附容量高于模拟胃液,但结合强度在模拟胃液中更强。
- 作者认为单次50 g活性炭在10:1比例下可能不足以应对安非他酮、米诺地尔和文拉法辛的临床显著过量。
适用人群与场景
- 涉及阿米替林、安非他酮、米诺地尔、普萘洛尔或文拉法辛过量、考虑胃肠道去污的患者(体外研究,未直接报告临床人群特征)。
研究设计与关键结果
- 体外研究:采用模拟胃液(pH 1.2)和模拟肠液(pH 6.8)进行动力学与吸附等温线实验,拟合Freundlich和Langmuir方程,确定各药达到≥95%吸附所需的活性炭药物比。
- 在模拟肠液中,安非他酮在活性炭药物比10:1时≥95%被吸附;模拟胃液中即使12:1也未达到该水平。
- 阿米替林和普萘洛尔在活性炭药物比低于10:1时达到≥95%吸附。
- 文拉法辛和米诺地尔需要更高的活性炭药物比才能达到最大吸附。
- 所有药物在模拟肠液中的最大吸附容量高于模拟胃液,但结合强度在模拟胃液中更强;安非他酮在模拟肠液中总体吸附更多,但效率随浓度升高而下降。
证据类型、等级与局限
- 证据类型:体外吸附等温线研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,单次50 g活性炭在10:1比例下可能不足以应对安非他酮、米诺地尔和文拉法辛的临床显著过量,尤其是速释安非他酮,其胃内吸附可能重要。
- 作者认为,药物特异性吸附差异提示需要细化给药策略,尤其是结合效率较低的药物。
- 研究支持在阿米替林、安非他酮、米诺地尔、普萘洛尔和文拉法辛过量中使用活性炭进行胃肠道去污。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Overdoses involving antidepressant and cardiovascular drugs account for 21.9% of non-opioid overdose-related fatalities in the United States. Activated charcoal is commonly used for gastrointestinal decontamination, but data regarding its adsorption efficacy for several clinically relevant drugs remain limited.
OBJECTIVE: We aimed to evaluate the adsorption of amitriptyline, bupropion, minoxidil, propranolol, and venlafaxine to activated charcoal by fitting adsorption isotherm data.
METHODS: Kinetics and adsorption isotherm experiments were conducted using simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 6.8). Freundlich and Langmuir isotherm equations were fitted to experimental data to model adsorption behavior. Drug-specific activated charcoal-to-drug ratios required to achieve ≥95% adsorption were identified.
RESULTS: All five drugs were adsorbed effectively to activated charcoal although adsorption efficiencies varied by pH. Maximal adsorption capacities of all drugs were higher in simulated intestinal fluid compared to simulated gastric fluid. In simulated intestinal fluid, ≥95% of bupropion was adsorbed at a 10:1 activated charcoal-to-drug ratio, while this level was not reached in simulated gastric fluid even at a 12:1 ratio. Amitriptyline and propranolol reached ≥95% adsorption at ratios below 10:1. Venlafaxine and minoxidil required higher ratios of activated charcoal ratios to reach maximal adsorption. Activated charcoal had a higher drug-binding capacity in simulated intestinal fluid, but binding was stronger in simulated gastric fluid. Bupropion was adsorbed more in simulated intestinal fluid overall, though efficiency decreased at higher concentrations.
DISCUSSION: A single 50 g dose of activated charcoal at 10:1 ratio may be inadequate for clinically significant overdoses of bupropion, minoxidil, and venlafaxine, especially for immediate release bupropion for which gastric adsorption may be important.
CONCLUSIONS: This study supports the use of activated charcoal for gastrointestinal decontamination in overdoses involving amitriptyline, bupropion, minoxidil, propranolol, and venlafaxine. However, drug-specific differences in adsorption behavior suggest a need for refined dosing strategies, particularly in cases involving drugs with lower binding efficiencies.
参考来源
- Wood HB, Trickett SM, Dosch JT, et al. Adsorption of antidepressant and cardiovascular drugs to activated charcoal: amitriptyline, bupropion, minoxidil, propranolol, and venlafaxine. Clin Toxicol (Phila). 2025. PMID: 40792620. doi:10.1080/15563650.2025.2532625
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。